MS is a chronic disease that affects the nervous system. Nerves are coated in a protective covering called myelin, which also speeds up the transmission of nerve signals. People with MS experience progressive deterioration of myelin.
Friday
Promising New Treatments for MS: VIDEO
MS is a chronic disease that affects the nervous system. Nerves are coated in a protective covering called myelin, which also speeds up the transmission of nerve signals. People with MS experience progressive deterioration of myelin.
Wednesday
Sunday
MS Patients Show Better Gait and Balance with Ampyra (Dalfampridine) Treatment
Withdrawal/reinitiation study expands on known walking speed benefits of approved MS therapy
In a new study, researchers evaluated the effect of dalfampridine treatment in people with multiple sclerosis (MS) and observed significant improvements in not only walking speed and distance, but also in gait and balance. The paper, titled “Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis,” was published in the International Journal of MS Care.
Thursday
Fampyra: Multiple Sclerosis patient welcomes claims that HSE looks set to fund a miracle drug
Gerard Murphy at the Royal Hospital in Donnybrook, Dublin
A Multiple Sclerosis patient has welcomed claims that the HSE looks set to fund a miracle drug.
Monday
Multiple Sclerosis sufferer blasts 'cruel' HSE for refusing to make wonder drug Fampyra free
Gerard Murphy at the Royal Hospital in Donnybrook , Dublin
A Multiple Sclerosis sufferer who was the first in the country to avail of a trial wonder drug has blasted the “cruel” HSE for refusing to make it widely available for free.
Relationship Between Timed 25-Foot Walk Impairment and Diffusion Tensor Imaging Markers in Multiple Sclerosis: STUDY
Image source: http://article.wn.com/
Sunday
Wednesday
Denis Naughten, TD, believes Ireland should be a pilot country for State-funded multiple sclerosis drug
Denis Naughten, TD
The Health Service Executive has rejected a second application from the makers of a drug that helps people with multiple sclerosis to walk to have it covered by State-funded drug schemes.
Medicinal marijuana drug means end to buying drugs on the street
The signing off of the introduction of a medicinal marijuana product, Savitex, in Ireland has been welcomed by Tom Curran, partner of the late Marie Fleming.
Wow! It's no wonder MS is seen as a Cash Cow: THESE MS DRUGS BROUGHT IN THE MOST MONEY LAST YEAR
Teva soaring out in front on a single product and it is no surprise that the Generics pack are waiting in the rear ready for the copaxone patents to expire starting May 2014. However Biogen are backing the most winners with a staggering $5.8 billion worth of business. #2 Avonex Biogen Idec $3.0 billion
#3 Gilenya Novartis $1.9 billion
#4 Tysabri Biogen Idec $1.7 billion
#5 Betaseron Bayer $1.1 billion
#6 Tecfidera Biogen Idec $0.9 billion
#7 Rebif EMD serono $0.6 billion
#8 Ampyra Biogen Idec $0.3 billion
#9 Aubagio Sanofi $0.2 billion
#10 Extavia Novartis $0.2 billion
Subscribe to:
Posts (Atom)